COVID-19 Impact on Global Oncology Biomarker Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: CE205D91B316EN
QYResearch

Abstracts

This report focuses on the global Oncology Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott Laboratories
• Bristol-Myers Squibb
• Eli Lilly and Company
• F.Hoffmann-La Roche Ltd.
• Genomic Health
• GlaxoSmithKline plc
• Novartis AG
• Merck & Co.
• Pfizer
• Qiagen N.V.

Market segment by Type, the product can be split into

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Others

Market segment by Application, split into

• Diagnostics
• Drug Discovery And Development
• Prognostics
• Risk Assessment
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Oncology Biomarker status, future forecast, growth opportunity, key market and key players.
• To present the Oncology Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Oncology Biomarker are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncology Biomarker Revenue
1.4 Market Analysis by Type
  1.4.1 Global Oncology Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Lung Cancer
  1.4.3 Breast Cancer
  1.4.4 Colorectal Cancer
  1.4.5 Prostate Cancer
  1.4.6 Stomach Cancer
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Oncology Biomarker Market Share by Application: 2020 VS 2026
  1.5.2 Diagnostics
  1.5.3 Drug Discovery And Development
  1.5.4 Prognostics
  1.5.5 Risk Assessment
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Oncology Biomarker Industry Impact
  1.6.1 How the Covid-19 is Affecting the Oncology Biomarker Industry
    1.6.1.1 Oncology Biomarker Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Oncology Biomarker Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Oncology Biomarker Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Oncology Biomarker Market Perspective (2015-2026)
2.2 Oncology Biomarker Growth Trends by Regions
  2.2.1 Oncology Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Oncology Biomarker Historic Market Share by Regions (2015-2020)
  2.2.3 Oncology Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Oncology Biomarker Market Growth Strategy
  2.3.6 Primary Interviews with Key Oncology Biomarker Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Oncology Biomarker Players by Market Size
  3.1.1 Global Top Oncology Biomarker Players by Revenue (2015-2020)
  3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2015-2020)
  3.1.3 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncology Biomarker Market Concentration Ratio
  3.2.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2019
3.3 Oncology Biomarker Key Players Head office and Area Served
3.4 Key Players Oncology Biomarker Product Solution and Service
3.5 Date of Enter into Oncology Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Oncology Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Oncology Biomarker Forecasted Market Size by Type (2021-2026)

5 ONCOLOGY BIOMARKER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Oncology Biomarker Market Size by Application (2015-2020)
5.2 Global Oncology Biomarker Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Oncology Biomarker Market Size (2015-2020)
6.2 Oncology Biomarker Key Players in North America (2019-2020)
6.3 North America Oncology Biomarker Market Size by Type (2015-2020)
6.4 North America Oncology Biomarker Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Oncology Biomarker Market Size (2015-2020)
7.2 Oncology Biomarker Key Players in Europe (2019-2020)
7.3 Europe Oncology Biomarker Market Size by Type (2015-2020)
7.4 Europe Oncology Biomarker Market Size by Application (2015-2020)

8 CHINA

8.1 China Oncology Biomarker Market Size (2015-2020)
8.2 Oncology Biomarker Key Players in China (2019-2020)
8.3 China Oncology Biomarker Market Size by Type (2015-2020)
8.4 China Oncology Biomarker Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Oncology Biomarker Market Size (2015-2020)
9.2 Oncology Biomarker Key Players in Japan (2019-2020)
9.3 Japan Oncology Biomarker Market Size by Type (2015-2020)
9.4 Japan Oncology Biomarker Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Oncology Biomarker Market Size (2015-2020)
10.2 Oncology Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oncology Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Oncology Biomarker Market Size by Application (2015-2020)

11 INDIA

11.1 India Oncology Biomarker Market Size (2015-2020)
11.2 Oncology Biomarker Key Players in India (2019-2020)
11.3 India Oncology Biomarker Market Size by Type (2015-2020)
11.4 India Oncology Biomarker Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Oncology Biomarker Market Size (2015-2020)
12.2 Oncology Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Oncology Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Oncology Biomarker Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Oncology Biomarker Introduction
  13.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Bristol-Myers Squibb
  13.2.1 Bristol-Myers Squibb Company Details
  13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
  13.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2015-2020)
  13.2.5 Bristol-Myers Squibb Recent Development
13.3 Eli Lilly and Company
  13.3.1 Eli Lilly and Company Company Details
  13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.3.3 Eli Lilly and Company Oncology Biomarker Introduction
  13.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2015-2020)
  13.3.5 Eli Lilly and Company Recent Development
13.4 F.Hoffmann-La Roche Ltd.
  13.4.1 F.Hoffmann-La Roche Ltd. Company Details
  13.4.2 F.Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
  13.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2015-2020)
  13.4.5 F.Hoffmann-La Roche Ltd. Recent Development
13.5 Genomic Health
  13.5.1 Genomic Health Company Details
  13.5.2 Genomic Health Business Overview and Its Total Revenue
  13.5.3 Genomic Health Oncology Biomarker Introduction
  13.5.4 Genomic Health Revenue in Oncology Biomarker Business (2015-2020)
  13.5.5 Genomic Health Recent Development
13.6 GlaxoSmithKline plc
  13.6.1 GlaxoSmithKline plc Company Details
  13.6.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
  13.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2015-2020)
  13.6.5 GlaxoSmithKline plc Recent Development
13.7 Novartis AG
  13.7.1 Novartis AG Company Details
  13.7.2 Novartis AG Business Overview and Its Total Revenue
  13.7.3 Novartis AG Oncology Biomarker Introduction
  13.7.4 Novartis AG Revenue in Oncology Biomarker Business (2015-2020)
  13.7.5 Novartis AG Recent Development
13.8 Merck & Co.
  13.8.1 Merck & Co. Company Details
  13.8.2 Merck & Co. Business Overview and Its Total Revenue
  13.8.3 Merck & Co. Oncology Biomarker Introduction
  13.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2015-2020)
  13.8.5 Merck & Co. Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Oncology Biomarker Introduction
  13.9.4 Pfizer Revenue in Oncology Biomarker Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 Qiagen N.V.
  13.10.1 Qiagen N.V. Company Details
  13.10.2 Qiagen N.V. Business Overview and Its Total Revenue
  13.10.3 Qiagen N.V. Oncology Biomarker Introduction
  13.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2015-2020)
  13.10.5 Qiagen N.V. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Oncology Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Oncology Biomarker Revenue
Table 3. Ranking of Global Top Oncology Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lung Cancer
Table 6. Key Players of Breast Cancer
Table 7. Key Players of Colorectal Cancer
Table 8. Key Players of Prostate Cancer
Table 9. Key Players of Stomach Cancer
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Oncology Biomarker Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Oncology Biomarker Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Oncology Biomarker Players to Combat Covid-19 Impact
Table 16. Global Oncology Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Oncology Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Oncology Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Oncology Biomarker Market Share by Regions (2015-2020)
Table 20. Global Oncology Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Oncology Biomarker Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Oncology Biomarker Market Growth Strategy
Table 26. Main Points Interviewed from Key Oncology Biomarker Players
Table 27. Global Oncology Biomarker Revenue by Players (2015-2020) (Million US$)
Table 28. Global Oncology Biomarker Market Share by Players (2015-2020)
Table 29. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2019)
Table 30. Global Oncology Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Oncology Biomarker Product Solution and Service
Table 33. Date of Enter into Oncology Biomarker Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 36. Global Oncology Biomarker Market Size Share by Type (2015-2020)
Table 37. Global Oncology Biomarker Revenue Market Share by Type (2021-2026)
Table 38. Global Oncology Biomarker Market Size Share by Application (2015-2020)
Table 39. Global Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 40. Global Oncology Biomarker Market Size Share by Application (2021-2026)
Table 41. North America Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Oncology Biomarker Market Share (2019-2020)
Table 43. North America Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 44. North America Oncology Biomarker Market Share by Type (2015-2020)
Table 45. North America Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 46. North America Oncology Biomarker Market Share by Application (2015-2020)
Table 47. Europe Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Oncology Biomarker Market Share (2019-2020)
Table 49. Europe Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Oncology Biomarker Market Share by Type (2015-2020)
Table 51. Europe Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Oncology Biomarker Market Share by Application (2015-2020)
Table 53. China Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 54. China Key Players Oncology Biomarker Market Share (2019-2020)
Table 55. China Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 56. China Oncology Biomarker Market Share by Type (2015-2020)
Table 57. China Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 58. China Oncology Biomarker Market Share by Application (2015-2020)
Table 59. Japan Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Oncology Biomarker Market Share (2019-2020)
Table 61. Japan Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Oncology Biomarker Market Share by Type (2015-2020)
Table 63. Japan Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Oncology Biomarker Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Oncology Biomarker Market Share (2019-2020)
Table 67. Southeast Asia Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Oncology Biomarker Market Share by Type (2015-2020)
Table 69. Southeast Asia Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Oncology Biomarker Market Share by Application (2015-2020)
Table 71. India Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 72. India Key Players Oncology Biomarker Market Share (2019-2020)
Table 73. India Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 74. India Oncology Biomarker Market Share by Type (2015-2020)
Table 75. India Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 76. India Oncology Biomarker Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Oncology Biomarker Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Oncology Biomarker Market Share (2019-2020)
Table 79. Central & South America Oncology Biomarker Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Oncology Biomarker Market Share by Type (2015-2020)
Table 81. Central & South America Oncology Biomarker Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Oncology Biomarker Market Share by Application (2015-2020)
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Product
Table 86. Abbott Laboratories Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 87. Abbott Laboratories Recent Development
Table 88. Bristol-Myers Squibb Company Details
Table 89. Bristol-Myers Squibb Business Overview
Table 90. Bristol-Myers Squibb Product
Table 91. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 92. Bristol-Myers Squibb Recent Development
Table 93. Eli Lilly and Company Company Details
Table 94. Eli Lilly and Company Business Overview
Table 95. Eli Lilly and Company Product
Table 96. Eli Lilly and Company Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 97. Eli Lilly and Company Recent Development
Table 98. F.Hoffmann-La Roche Ltd. Company Details
Table 99. F.Hoffmann-La Roche Ltd. Business Overview
Table 100. F.Hoffmann-La Roche Ltd. Product
Table 101. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 102. F.Hoffmann-La Roche Ltd. Recent Development
Table 103. Genomic Health Company Details
Table 104. Genomic Health Business Overview
Table 105. Genomic Health Product
Table 106. Genomic Health Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 107. Genomic Health Recent Development
Table 108. GlaxoSmithKline plc Company Details
Table 109. GlaxoSmithKline plc Business Overview
Table 110. GlaxoSmithKline plc Product
Table 111. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 112. GlaxoSmithKline plc Recent Development
Table 113. Novartis AG Company Details
Table 114. Novartis AG Business Overview
Table 115. Novartis AG Product
Table 116. Novartis AG Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 117. Novartis AG Recent Development
Table 118. Merck & Co. Business Overview
Table 119. Merck & Co. Product
Table 120. Merck & Co. Company Details
Table 121. Merck & Co. Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 122. Merck & Co. Recent Development
Table 123. Pfizer Company Details
Table 124. Pfizer Business Overview
Table 125. Pfizer Product
Table 126. Pfizer Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 127. Pfizer Recent Development
Table 128. Qiagen N.V. Company Details
Table 129. Qiagen N.V. Business Overview
Table 130. Qiagen N.V. Product
Table 131. Qiagen N.V. Revenue in Oncology Biomarker Business (2015-2020) (Million US$)
Table 132. Qiagen N.V. Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Oncology Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Lung Cancer Features
Figure 3. Breast Cancer Features
Figure 4. Colorectal Cancer Features
Figure 5. Prostate Cancer Features
Figure 6. Stomach Cancer Features
Figure 7. Others Features
Figure 8. Global Oncology Biomarker Market Share by Application: 2020 VS 2026
Figure 9. Diagnostics Case Studies
Figure 10. Drug Discovery And Development Case Studies
Figure 11. Prognostics Case Studies
Figure 12. Risk Assessment Case Studies
Figure 13. Others Case Studies
Figure 14. Oncology Biomarker Report Years Considered
Figure 15. Global Oncology Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Oncology Biomarker Market Share by Regions: 2020 VS 2026
Figure 17. Global Oncology Biomarker Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Oncology Biomarker Market Share by Players in 2019
Figure 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biomarker as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2019
Figure 22. North America Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Oncology Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 31. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 33. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 35. F.Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 37. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 39. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 41. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 43. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 45. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 47. Qiagen N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed